Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Multiple Sclerosis

  Free Subscription


1 Int J Neurosci
1 J Neurol
5 Mult Scler
1 Neurologia
2 Neurology
2 Proc Natl Acad Sci U S A
1 Rev Neurol (Paris)

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Int J Neurosci

    Understanding Visual-Spatial Perceptual Deficits in Individuals with Multiple Sclerosis: An Analysis of Patient Performance on the Hooper Visual Organization Test and Visual Form Discrimination.
    Int J Neurosci. 2021 Jul 13:1-9. doi: 10.1080/00207454.2021.1954642.
    PubMed         Abstract available

    J Neurol

  2. RAUMA I, Mustonen T, Seppa JM, Ukkonen M, et al
    Safety of alemtuzumab in a nationwide cohort of Finnish multiple sclerosis patients.
    J Neurol. 2021 Jul 13. pii: 10.1007/s00415-021-10664.
    PubMed         Abstract available

    Mult Scler

  3. HOGESTOL EA, Ghezzo S, Nygaard GO, Espeseth T, et al
    Functional connectivity in multiple sclerosis modelled as connectome stability: A 5-year follow-up study.
    Mult Scler. 2021 Jul 14:13524585211030212. doi: 10.1177/13524585211030212.
    PubMed         Abstract available

  4. WIJERATNE T, Carroll W
    World Brain Day 2021: Global campaign to stop multiple sclerosis.
    Mult Scler. 2021 Jul 14:13524585211030147. doi: 10.1177/13524585211030147.

  5. MONTALBAN X, Graves J, Midaglia L, Mulero P, et al
    A smartphone sensor-based digital outcome assessment of multiple sclerosis.
    Mult Scler. 2021 Jul 14:13524585211028561. doi: 10.1177/13524585211028561.
    PubMed         Abstract available

  6. BOUMAN PM, Strijbis VI, Jonkman LE, Hulst HE, et al
    Artificial double inversion recovery images for (juxta)cortical lesion visualization in multiple sclerosis.
    Mult Scler. 2021 Jul 14:13524585211029860. doi: 10.1177/13524585211029860.
    PubMed         Abstract available

  7. LONGINETTI E, Frisell T, Englund S, Reutfors J, et al
    Risk of depression in multiple sclerosis across disease-modifying therapies.
    Mult Scler. 2021 Jul 15:13524585211031128. doi: 10.1177/13524585211031128.
    PubMed         Abstract available


  8. JIMENEZ-MORALES RM, Broche-Perez Y, Macias-Delgado Y, Sebrango C, et al
    Cognitive rehabilitation program in patients with multiple sclerosis: A pilot study.
    Neurologia. 2021 Jul 9. pii: S0213-4853(21)00088.
    PubMed         Abstract available


  9. NICHOLAS RS, Rhone EE, Mariottini A, Silber E, et al
    Autologous Haematopoietic Stem Cell Transplantation in Active Multiple Sclerosis: a Real-world Case Series.
    Neurology. 2021 Jul 12. pii: WNL.0000000000012449.
    PubMed         Abstract available

  10. HACOHEN Y, Kerr W, Waters P
    Intrathecal Production of MOG-IgG: Highlighting the Need for CSF Testing in Clinical Practice.
    Neurology. 2021;97:12-13.

    Proc Natl Acad Sci U S A

  11. HUHN K, Linz P, Pemsel F, Michalke B, et al
    Skin sodium is increased in male patients with multiple sclerosis and related animal models.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available

  12. Correction for Ostkamp et al., Sunlight exposure exerts immunomodulatory effects to reduce multiple sclerosis severity.
    Proc Natl Acad Sci U S A. 2021;118.

    Rev Neurol (Paris)

  13. LEBLANC S, Roux J, Tillaut H, Le Page E, et al
    Disease-modifying therapy usage in patients with multiple sclerosis in France: A 6-year population-based study.
    Rev Neurol (Paris). 2021 Jul 9. pii: S0035-3787(21)00587.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Multiple Sclerosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.